News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
213,120 Results
Type
Article (15064)
Company Profile (33)
Press Release (198022)
Multimedia
Podcasts (24)
Webinars (3)
Section
Business (58180)
Career Advice (559)
Deals (8137)
Drug Delivery (43)
Drug Development (20406)
Employer Resources (41)
FDA (5308)
Job Trends (5843)
News (96916)
Policy (12685)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (1648)
Academic (1)
Accelerated approval (10)
Adcomms (8)
Allergies (38)
Alliances (17964)
ALS (43)
Alzheimer's disease (592)
Antibody-drug conjugate (ADC) (80)
Approvals (5507)
Artificial intelligence (146)
Autoimmune disease (40)
Automation (22)
Bankruptcy (70)
Best Places to Work (4876)
BIOSECURE Act (15)
Biosimilars (50)
Biotechnology (22)
Bladder cancer (63)
Brain cancer (27)
Breast cancer (247)
Cancer (1824)
Cardiovascular disease (91)
Career advice (487)
Career pathing (3)
CAR-T (70)
CDC (23)
Celiac Disease (1)
Cell therapy (171)
Cervical cancer (26)
Clinical research (16904)
Collaboration (529)
Company closure (1)
Compensation (16)
Complete response letters (10)
COVID-19 (1379)
CRISPR (26)
C-suite (204)
Cystic fibrosis (46)
Data (1810)
Decentralized trials (1)
Denatured (6)
Depression (34)
Diabetes (117)
Diagnostics (4083)
Digital health (17)
Diversity (3)
Diversity, equity & inclusion (14)
Drug discovery (72)
Drug pricing (107)
Drug shortages (8)
Duchenne muscular dystrophy (61)
Earnings (16027)
Editorial (18)
Employer branding (5)
Employer resources (34)
Events (24609)
Executive appointments (256)
FDA (6294)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (468)
Gene editing (41)
Generative AI (10)
Gene therapy (145)
GLP-1 (217)
Government (2923)
Grass and pollen (4)
Guidances (114)
Healthcare (7785)
HIV (26)
Huntington's disease (4)
IgA nephropathy (23)
Immunology and inflammation (27)
Immuno-oncology (18)
Indications (40)
Infectious disease (1489)
Inflammatory bowel disease (36)
Inflation Reduction Act (5)
Influenza (53)
Intellectual property (51)
Interviews (89)
IPO (3020)
IRA (18)
Job creations (1131)
Job search strategy (434)
JPM (19)
Kidney cancer (6)
Labor market (26)
Layoffs (82)
Leadership (6)
Legal (2636)
Liver cancer (22)
Lung cancer (263)
Lymphoma (168)
Machine learning (12)
Management (12)
Manufacturing (273)
MASH (23)
Medical device (3058)
Medtech (3067)
Mergers & acquisitions (5340)
Metabolic disorders (240)
Multiple sclerosis (44)
NASH (1)
Neurodegenerative disease (75)
Neuropsychiatric disorders (12)
Neuroscience (884)
NextGen: Class of 2026 (2916)
Non-profit (3298)
Now hiring (19)
Obesity (93)
Opinion (74)
Ovarian cancer (35)
Pain (58)
Pancreatic cancer (54)
Parkinson's disease (58)
Partnered (13)
Patents (96)
Patient recruitment (106)
Peanut (12)
People (20020)
Pharmaceutical (6)
Pharmacy benefit managers (13)
Phase 1 (4829)
Phase 2 (7035)
Phase 3 (6254)
Pipeline (1519)
Policy (149)
Postmarket research (788)
Preclinical (2316)
Press Release (22)
Prostate cancer (97)
Psychedelics (7)
Radiopharmaceuticals (76)
Rare diseases (220)
Real estate (2762)
Recruiting (17)
Regulatory (8771)
Reports (13)
Research institute (1538)
Resumes & cover letters (72)
Rett syndrome (2)
RSV (27)
Schizophrenia (37)
Series A (47)
Series B (30)
Sickle cell disease (27)
Special edition (3)
Spinal muscular atrophy (50)
Sponsored (15)
Startups (1042)
State (1)
Stomach cancer (3)
Supply chain (41)
Tariffs (55)
The Weekly (18)
Vaccines (346)
Venture capital (17)
Weight loss (66)
Women's health (35)
Worklife (2)
Date
Today (44)
Last 7 days (167)
Last 30 days (548)
Last 365 days (7458)
2026 (839)
2025 (7501)
2024 (9009)
2023 (10651)
2022 (15687)
2021 (17431)
2020 (18606)
2019 (17781)
2018 (13385)
2017 (9380)
2016 (10048)
2015 (11100)
2014 (8637)
2013 (7241)
2012 (7727)
2011 (8229)
2010 (6955)
Location
Africa (311)
Alabama (19)
Alaska (2)
Arizona (104)
Arkansas (9)
Asia (13760)
Australia (2154)
California (2318)
Canada (931)
China (520)
Colorado (119)
Connecticut (125)
Delaware (108)
Europe (23926)
Florida (402)
Georgia (82)
Idaho (19)
Illinois (247)
India (27)
Indiana (161)
Iowa (4)
Japan (152)
Kansas (47)
Kentucky (14)
Louisiana (10)
Maine (28)
Maryland (493)
Massachusetts (1490)
Michigan (114)
Minnesota (112)
Mississippi (3)
Missouri (94)
Montana (13)
Nebraska (7)
Nevada (49)
New Hampshire (18)
New Jersey (1007)
New Mexico (15)
New York (854)
North Carolina (363)
North Dakota (1)
Northern California (1074)
Ohio (96)
Oklahoma (7)
Oregon (11)
Pennsylvania (521)
Puerto Rico (4)
Rhode Island (16)
South America (367)
South Carolina (16)
South Dakota (1)
Southern California (951)
Tennessee (71)
Texas (557)
United States (9881)
Utah (107)
Vermont (1)
Virginia (72)
Washington D.C. (20)
Washington State (244)
West Virginia (2)
Wisconsin (42)
Wyoming (1)
213,120 Results for "argonne national laboratory".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Shine On: Argonne’s Upgraded Advanced Photon Source Sees First X-ray Light for Science
A new era of science at the Advanced Photon Source is ready to begin. On June 17, 2024, the facility at the U.S. Department of Energy’s Argonne National Laboratory delivered its first X-ray light beams to a scientific beamline as part of a comprehensive and complex upgrade.
June 18, 2024
·
2 min read
Opinion
Fate of FDA’s Laboratory-Developed Testing Final Rule Hints at
Chevron
Overturn’s Ramifications
In one of the first demonstrations of the impact of last year’s Loper Supreme Court decision on challenges to agency authority, a judge ruled that the FDA does not have authority to regulate tests developed by clinical laboratories.
September 29, 2025
·
4 min read
·
Megan Robertson
FDA
J&J Wins Proactive FDA National Priority Voucher for Multiple Myeloma Combo
Johnson & Johnson, which did not apply for the national priority voucher, was granted the ticket based on results from a Phase III study testing Tecvayli plus Darzalex in patients with relapsed or refractory multiple myeloma.
December 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
National Organization for Rare Disorders Ranks All 50 States on Rare Disease Policies
February 10, 2026
·
4 min read
Press Releases
Minaris Announces Viral Clearance Laboratory Upgrade at Philadelphia Campus
January 28, 2026
·
3 min read
Press Releases
Charles River Laboratories Provides Business Updates
January 13, 2026
·
14 min read
Press Releases
bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board
February 10, 2026
·
5 min read
Press Releases
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
January 8, 2026
·
5 min read
Press Releases
Pangea Laboratory and Gene Solutions Establish Strategic Collaboration to Advance Cancer Diagnostics in the United States
January 21, 2026
·
4 min read
Press Releases
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
January 28, 2026
·
5 min read
1 of 21,312
Next
